Background/Aims: Renal ischemia/reperfusion (I/R) injury (RI/RI) is a common complication of diabetes, and it may be involved in altering intracellular calcium concentrations at its onset, which can result in inflammation, abnormal lipid metabolism, the production of reactive oxygen species (ROS), and nitroso-redox imbalance. The calcium-sensing receptor (CaSR) is a G-protein coupled receptor, however, the functional involvement of CaSR in diabetic RI/ RI remains unclear. The present study was intended to investigate the role of CaSR on RI/RI in diabetes mellitus (DM). Methods: The bilateral renal arteries and veins of streptozotocin (STZ)-induced diabetic rats were subjected to 45-min ischemia followed by 2-h reperfusion with or without R-568 (agonist of CaSR) and NPS-2143 (antagonist of CaSR) at the beginning of I/R procedure. DM without renal I/R rats served as control group. The expressions of CaSR, calmodulin (CaM), and p47phox in the renal tissue were analyzed by qRT-PCR and Western blot. The renal pathomorphology, renal function, oxidative stress, inflammatory response, and calcium disorder were evaluated by detection of a series of indices by hematoxylin-eosin (HE) staining, transmission electron microscope (TEM), commercial kits, enzyme-linked immunosorbent assay (ELISA), and spectrophotofluorometry, respectively. Results: Results showed that the expressions of CaSR, CaM, and p47phox in I/R group were significantly up-regulated as compared with those in DM group, which were accompanied by renal tissue injury, increased calcium, oxidative stress, inflammation, and nitroso-redox imbalance. Conclusion: These results suggest that activation of CaSR is involved in the induction of damage of renal tubular epithelial cell during diabetic RI/RI, resulting in lipid peroxidation, inflammatory response, nitroso-redox imbalance, and apoptosis.

The kidney is a vital organ for eliminating toxic substances from the blood and regulating water, electrolyte and acid-base balance in the body. In other respects, however, the kidney is vulnerable to damage by many disease processes given such as renal ischemia/ reperfusion (I/R) injury (RI/RI) during the perioperative period [1, 2]. Renal sensitivity to I/R injury is found to be increased in streptozotocin (STZ)-induced diabetic rats [3], and in fact, RI/RI frequently occurs in diabetic patients [4] and often emerges as one of the dangerous complications of this procedure [5, 6]. In such a condition, patients may need renal transplantation in their later life when diabetic nephropathy occurs [7]. It is assumed that in diabetic rats, a comparatively short ischemia of 30 minutes is a predisposing factor contributing to the reversible acute kidney injury (AKI), causing a progressive injury with early-stage renal failure [4, 8, 9]. Clarification of the underlying mechanism is pivotal for determining efficacious management for diabetic RI/RI. Mounting studies have previously demonstrated that the underlying mechanism of I/R injury, including RI/RI mainly involves inflammatory cascade, reactive oxygen species (ROS), abnormal lipid metabolism, nitrosoredox imbalance, and calcium overload from ischemic tissues during reperfusion of ischemic tissues that may act indirectly in redox signaling to turn on apoptosis [10, 11].

The calcium-sensing receptor (CaSR), a G-protein coupled receptor with a large extracellular domain (ECD) in the N-terminal portion of the receptor, a seven-transmembrane region, and an intracellular carboxyl-terminal tail, is primarily expressed in the parathyroid gland and the renal tubules of the kidney [12-15]. Intriguingly, abundant data have demonstrated that activation of CaSR can exacerbate RI/RI [16] and is implicated in the pathogenesis of diabetes mellitus (DM) [17-19]. Intracellular calcium can be released through the binding of calcium to the ECD of CaSR activated Gq proteins, stimulated phospholipase C activity, and an increase in intracellular inositol triphosphate 3 level [20, 21]. The change in intracellular calcium is involved in many cell activities, such as cell proliferation and apoptosis. Ample evidence shows that extracellular calcium can be absorbed and transported into mitochondria during I/R, leading to changes of mitochondria membrane and promoting the activation of oxidative stress and apoptosis [22-24].

Previous studies showed that CaSR expressed in myocardial tissues played an important role in increased intracellular calcium during I/R injury [13, 21, 25, 26]. However, little is known about whether changes of CaSR expression induce renal injury during diabetic RI/RI. Herein, we took advantage of a conventional STZ-induced diabetic rat model of bilateral clamping of renal pedicles to investigate the impact of CaSR activation on diabetic RI/RI.

Animal models and treatment protocols

Sprague-Dawley rats (200-220 g) were obtained from the Laboratory Animal Unit of Jiaxing University, and were housed with a 12-/12-h light/dark cycle with ad libitum access to standard rodent chow and water. All experimental procedures were approved by the Ethics Committee for Animal Care and Use at the Jiaxing University (No. JUMC2015-029). The STZ-induced diabetic rat model was generated with i.p. injection of STZ dissolved in 0.1 M citrate buffer (PH 4.5, 50 mg/kg body weight [bw]). Rats with serum glucose levels ≥16.7 mmol/L in three consecutive measurements (three consecutive days) were considered to be a successful diabetic rat model [27].

Forty STZ-induced diabetic rats were housed for 5 days and generally anesthetized by i.p. injection with 2 % (w/w) pentobarbital sodium (3.0 ml/kg bw) [28, 29]. Then they were equally randomized into four groups: (1) STZ-induced diabetic rat (DM group), wherein the diabetic rats were treated only with separating the bilateral renal arteries and veins; (2) DM + renal I/R injury (I/R group), wherein the diabetic rats were treated with ischemia by clamping the bilateral renal arteries and veins for 45 min and subsequent 2-h reperfusion; (3) DM + renal I/R injury + R-568 group (R group), wherein the R-568 (an agonist of CaSR, 2.5 mg/kg bw, dissolved in 10% dimethyl sulphoxide) was administered by i.p. injection to diabetic rats at 30 min prior to the I/R procedure; and (4) DM + renal I/R injury + NPS-2143 group (NPS group), wherein the NPS-2143 (an antagonist of CaSR, 30 mg/kg bw, dissolved in 15% aqueous solution of 2-hydroxypropyl-β-cyclodextrin) was administered by i.p. injection to diabetic rats at 30 min prior to the I/R procedure.

All animals were terminated under general anesthesia, blood and kidneys were collected and snap-frozen for biochemical and histological analysis. Blood samples were obtained from the abdominal aorta after reperfusion. Blood was washed away from the resected kidney with ultrapure water. All the resected left kidneys per group were used for evaluating renal histopathologic alterations and ultrastructural changes of renal epithelial cells of proximal tubules. The resected right kidneys per group were homogenized in ice-cold normal saline and then centrifuged at 4 °C at 3,600× g for 15 min to harvest the supernatant.

Detection of renal function and assessment of oxidative stress and inflammation in the renal tissue

The serum levels of blood urea nitrogen (BUN) and serum creatinine (Scr) and the levels of superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH) in the rat renal tissue were measured with the Clinical Automatic Biochemistry Analyzer 7600 (Hitachi, Japan) employing a kit provided by Roche Diagnostics (Mannheim, Germany). The levels of interleukin-10 (IL-10), IL-6, and nitric oxide (NO) in the rat renal tissue were measured by the double antibody sandwich enzyme-linked immunosorbent assay (ELISA) kits (Roche) according to the manufacturer’s instructions.

Histopathological evaluation of renal damages

The left renal tissue was fixed in 10% neutral formalin solution, paraffin-embedded, sliced into 4-µm sections, stained with hematoxylin-eosin (HE) staining. One whole deep coronal section was examined under the optical microscope (Leica, Germany) and graded according to the degree of damage based on the percentage of involvement of the kidney. The damage quantification from ten areas corresponding to the renal tissue was graded using the following parameters: tubular cell necrosis, apoptosis, cytoplasmic vacuole formation, hemorrhage, and tubular dilatation based on a five-score system (1, histopathological changes <10%; 2, = 10-25%; 3, =25-50%; 4, =50-75%; and 5, =75-100%). The mean score for each parameter was calculated and subjected to statistical analysis [9, 30].

Detection of ultrastructural changes of renal proximal tubular endothelial cells

The renal cortical tissue was sliced into small size (1 × 1 × 1 mm), fixed in 4% (v/v) glutaraldehyde at room temperature overnight, and then post-fixed in 1% (v/v) osmium tetroxide for 2 h. The fixed tissue was dehydrated using ascending grades of ethanol, epoxy resin-embedded, sliced into 60-70 nm ultrathin sections, placed on 300 mesh copper grids covered by carbon formvar, stained with uranyl acetate and lead citrate, and observed under transmission electron microscopy (TEM) (Hitachi, Japan) operating at 80 kV. The section was assessed by an electron microscopy technician who was blinded to the treatments.

Calcium determination in the renal tissue

The renal cortical interstitial tissue was severed and thoroughly rinsed off the residual blood with ice-cold ultrapure water produced by a Milli-QRG water purification system (Millipore, France). The kidney proximal tubule was mechanically isolated under a microscope. Further, the samples (ca. 200 mg) were placed directly in the decontaminated microwave digestion vessels. Next, they were digested with 3.0 mL of concentrated (65 % w/w) HNO3 and 1.0 mL of (30% v/v) H2O2 solution (Yongda, Tianjin, China) in an intelligence microwave digestion/extraction instrument (Xintuo, Shanghai, China), under a pressure (MPa)/time (min) program: 20/1, 0/2, 10/2, 20/2, and 10/3. After cooling, the mixtures were made up to 10 mL with ultrapure water and stored in closed propylene tubes at 4 °C for use. Ca quantifications were performed by inductively coupled plasma atomic emission spectrophotometry (ICP-AES) (Bohui Innovation Technology, Beijing, China) as described previously [31-33]. Briefly, the aliquots of the mixtures were mineralized with nitric/sulfuric/perchloric acid (3: 1:1, v/v) in closed Teflon vessels in order to eliminate interference from the organic matrixes. The achromatous and homogeneous diluted digestions, which were diluted with ultrapure water to reduce the nitric acid level, were nebulized in argon plasma. The reference wavelength was 193.091 nm (the atomic line of carbon emission) for monitoring the remaining undigested organic materials.

Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR)

Total RNA was isolated from the prepared renal samples using TRIzol reagent (Invitrogen, USA). cDNA was synthesized by reverse transcription following the manufacturer’s protocols (MBI Fermentas, Lithuania). qRT-PCR was performed with a standard SYBR-green PCR kit (Toyobo, Japan), and gene-specific PCR amplification was performed using the ABI 7300 (Applied Biosystems, Germany). The primers sequences were shown in Table 1. Relative gene expression levels were calculated using the 2-ΔΔCt method after normalization to the expression of GAPDH.

Western blot analysis

The renal tissue homogenate was electrophoretically separated in 10% SDS-PAGE gel and transferred to a nitrocellulose membrane. Aspecific binding of antibodies was blocked using 5% skimmed milk in Tris-buffered saline-0.1% Tween-20 (TBST) for 1 hour. The membrane was incubated with primary antibodies (against active CaSR, calcium-modulated protein (calmodulin, CaM), and neutrophil cytosol factor 1 (p47phox)) overnight at 4°C and subsequently with the alkaline phosphatase-conjugated secondary antibodies. The protein level was normalized with respect to β-actin band density. The antigen-antibody product was measured by Thermo Scientific Super Signal West Pico Chemiluminescent Substrate (Thermo, USA) and analyzed with a Fluor Chem system (Alpha, USA).

Statistical analysis

All experiments were repeated in triplicate. Statistical analysis was carried out using SPSS (v19.0) software, and the processed data were reported in the form of mean ± standard deviation (SD). Mean comparison between multiple groups was realized using single-factor analysis of variance (ANOVA) with posthoc Dunn’s multiple comparison tests. A p<0.05 or 0.01 was considered to represent statistical significance.

Changes of the renal function in different groups

Compared with DM group, the serum levels of BUN and Scr were significantly increased in I/R group. They were further elevated by R-568 pretreatment, and decreased by NPS-2143 preconditioning (p<0.01) (Fig. 1). These results suggest that R-568 and NPS-2143 may regulate I/R-induced renal damage in diabetic rats.

Fig. 1.

Histopathological and ultrastructure alterations of kidneys and renal function. Note: Under the light microscope (HE, ×200), the renal proximal tubules show vacuolar degeneration and apoptosis in I/R group (arrow), while these alterations were markedly increased in R-568 group (arrow) and reduced in NPS-2143 group. Under the TEM (the scale bar is 2 µm), The nuclear chromatin margination (arrow) are observed in I/R group. The damages are aggravated by the agonist of CaSR R-568 pretreatment (karyopyknosis, arrow) and limited by the antagonist of CaSR NPS-2143 preconditioning. (A) Injury scores of the kidney; (B) Renal function. *p˂0.001 vs. DM group; **p˂0.01 vs. I/R group.

Fig. 1.

Histopathological and ultrastructure alterations of kidneys and renal function. Note: Under the light microscope (HE, ×200), the renal proximal tubules show vacuolar degeneration and apoptosis in I/R group (arrow), while these alterations were markedly increased in R-568 group (arrow) and reduced in NPS-2143 group. Under the TEM (the scale bar is 2 µm), The nuclear chromatin margination (arrow) are observed in I/R group. The damages are aggravated by the agonist of CaSR R-568 pretreatment (karyopyknosis, arrow) and limited by the antagonist of CaSR NPS-2143 preconditioning. (A) Injury scores of the kidney; (B) Renal function. *p˂0.001 vs. DM group; **p˂0.01 vs. I/R group.

Close modal

Pathological alterations in the kidneys of model rats viewed by light microscopy and TEM

Under the optical microscope, several hemorrhagic lesions were observed. The renal proximal tubules showed varying degrees of vacuolar degeneration and apoptosis in I/R group. These histopathological alterations were markedly increased in R-568 group (sporadic necrosis of epithelial cells and infiltration of inflammatory cells) and reduced in NPS-2143 group (Fig. 1). We detected ultrastructural abnormalities in proximal tubular endothelial cells of the kidneys in diabetic RI/RI rats by TEM, such as swelling of the cytoplasm, endoplasmic reticulum changes, swelling of the mitochondria with the loss of cristae, nuclear chromatin margination, and karyopyknosis. The chromatin margination, and mitochondrion swell and vacuole change were observed in I/R group. The ultrastructural damages were aggravated by the agonist of CaSR R-568 pretreatment and limited by the antagonist of CaSR NPS-2143 preconditioning (Fig. 1). These abnormalities suggest that the tubular endothelial cells undergo a stage of asphyxia and start dying from the dead mitochondria and nuclei after I/R treatment. CaSR may exert a critical role in this pathological process.

SOD activity and the levels of MDA and GSH in the renal tissue

To evaluate the role of CaSR in renal I/R-induced oxidative stress in diabetic rats, SOD activity and the levels of MDA and GSH were detected in the renal tissue. As shown in Fig. 2, as compared with I/R group, SOD activity and GSH level in R-568 group and MDA level in NPS-2143 group were both significantly decreased, while SOD activity and GSH level in NPS-2143 group and MDA level in R-568 group were significantly increased (p<0.01). The results indicate that CaSR participates in oxidative stress of diabetic RI/RI, which can be modulated by its regulators.

Fig. 2.

Antioxidant activation of the renal tissue. Note: *p<0.001 vs. DM group; **p<0.01 vs. I/R group.

Fig. 2.

Antioxidant activation of the renal tissue. Note: *p<0.001 vs. DM group; **p<0.01 vs. I/R group.

Close modal

The mRNA and protein expression of CaSR in the renal tissue

CaSR is substantially expressed within the renal tissue and has been implicated in a variety of functions in kidneys. In our study, the expression of CaSR in the renal tissue was detected by qRT-PCR and Western blot. The expressions of CaSR in I/R and R-568 preconditioning groups were up-regulated compared to DM group. NPS-2143 could inhibit the expressions (p<0.01) (Fig. 3). The results show that the expression of CaSR is increased in diabetic RI/RI, and R-568 can up-regulate the expression of CaSR, while NPS-2143 can down-regulate the expression of CaSR.

Fig. 3.

The expression of CaSR and Ca level in the renal tissue. Note: (A) Protein expression of CaSR, (B) Relative mRNA expression of CaSR, (C) Ca level, (D) Protein expression of CaM and p47phox, (E) Relative mRNA expression of CaM and p47phox. *p<0.001 vs. DM group; **p<0.01 vs. I/R group.

Fig. 3.

The expression of CaSR and Ca level in the renal tissue. Note: (A) Protein expression of CaSR, (B) Relative mRNA expression of CaSR, (C) Ca level, (D) Protein expression of CaM and p47phox, (E) Relative mRNA expression of CaM and p47phox. *p<0.001 vs. DM group; **p<0.01 vs. I/R group.

Close modal

Ca level in the renal tissue

Ca2+ plays an important role in regulating nuclear functions, including cell growth and death. Results showed that Ca level was increased significantly in I/R (160.47±15.24 nM) and R-568 groups (187.82±18.76 nM) as compared with that in DM group (82.59±8.48 nM) (p<0.01). Ca concentration was decreased significantly in NPS-2143 group (143.19±11.27 nM) as compared with that in I/R group (p<0.01) (Fig. 3). These results indicate that diabetic I/R-induced renal injury can up-regulate CaSR expression that triggers a feedforward signaling mechanism in which elevates Ca level.

The mRNA and protein expressions of CaM and p47phox in the renal tissue

CaM, a multifunctional intermediate calcium-binding messenger protein, acts as part of a calcium signal transduction pathway by modifying its interactions with various target proteins such as kinases or phosphatases [34]. p47phox is vital to the activation of NADPH oxidase for producing superoxide anion [35]. We found that the mRNA expressions of CaM and p47phox were up-regulated by 4.48- to 8.02-fold after I/R and R-568 preconditioning. NPS-2143 could inhibit the mRNA expressions of them (p<0.01). Correspondingly, the protein expressions of CaM and p47phox were increased significantly in I/R group and R-568 preconditioning group as compared with those in DM group (p<0.01). They were decreased significantly in NPS-2143 preconditioning group (p<0.01) (Fig. 3).

The levels of IL-10, IL-6, and NO in the renal tissue

NO is biosynthesized endogenously from L-arginine, oxygen, and NADPH by various NOS enzymes, playing a role in a variety of biological processes [36]. To evaluate the inflammatory reactions, the levels of IL-10 (anti-inflammatory factor) and IL-6 (pro-inflammatory factor) in the renal tissue were also measured. The mean levels of IL-10, IL-6, and NO were significantly increased in I/R group as compared with those in DM group (p<0.01). Preconditioning with the agonist of CaSR R-568 further enhanced significantly the levels of IL-6 and NO, and decreased markedly IL-10 level (p<0.01) (Fig. 4). These results indicate that CaSR acts a vital role in diabetic RI/RI, which involves in the increase of [Ca2+], oxidative stress, inflammation, and apoptosis.

Fig. 4.

The levels of IL-10, IL-6, and NO in the renal tissue. Note: (A) IL-10, (B) IL-6, and (C) NO. *p<0.001 vs. DM group; **p<0.01 vs. I/R group.

Fig. 4.

The levels of IL-10, IL-6, and NO in the renal tissue. Note: (A) IL-10, (B) IL-6, and (C) NO. *p<0.001 vs. DM group; **p<0.01 vs. I/R group.

Close modal

It is well documented that the clinical mortality in diabetic patients with acute kidney injury (AKI) is often increased as a result of multi-organ dysfunction and progression of MOF [32, 37, 38]. To explore the underlying molecular mechanisms on diabetic RI/RI, the establishment of a reliable animal model is critical. In the present study, single dose of STZ-induced diabetes mellitus offered a very cost-effective and expeditious technique. The surveillance of serum glucose levels, impaired renal function, and pathomorphological injuries indicated the successful establishment of the diabetic RI/RI model.

In the current study, we established a diabetic RI/RI model to assess the renal function, knowing that this model mimics the pathological conditions observed in humans where blood supply of both kidneys was normally reduced [39-41]. In recent years, considerable circumstantial evidence has indicated a role for diabetes-induced oxidative stress, which is routinely accompanied by diabetic renal I/R-induced renal damages. Oxidative stress contributes to increased cellular damage and death through protein oxidation, DNA damage, and peroxidation of membrane lipids [33]. High MDA and protein carbonyl levels are two major indices for oxidative stress [42]. It was found in our study that the activity of SOD and GSH level were decreased while the MDA level was increased in the renal tissue in diabetic RI/RI, demonstrating an oxidative injury. During the process of I/R injury, inflammatory reactions are activated, resulting in the formation of inflammatory cytokines, such as IL-6 and IL-10 [9, 27, 43, 44]. We also found that the expressions of IL-10 and IL-6 in the renal tissue were elevated in this diabetic RI/RI model. These results confirmed the inflammatory injury in kidneys due to renal I/R. Neutrophils are known as major cells for ROS production, and play a role in oxidative injury via the action of NADPH oxidase [5, 45, 46]. p47phox, an NADPH oxidase subunit, was significantly up-regulated in the present model. Another probable mechanism involved in ROS production might be associated with the NO system. It was found that DM could increase the activity and expression of renal and myocardial iNOS in STZ-induced diabetic rats, and NO level was elevated in the diabetic kidney in the early stage [30, 47]. CaM and Ca2+ can activate the NOS in the cytoplasm, which can catalyze the formation of NO. Likewise, we observed that NO level was increased in the renal tissue, as accompanied by the increased Ca level and CaM expression, suggesting a disruption in nitroredox homeostasis.

The overexpression of CaSR protein resulted in disturbance of calcium homeostasis, induced the alteration of a series of downstream signaling pathways, or directly injured cellular structure through mitochondrial and nuclear dysfunction. The results of HE staining and TEM showed varying degrees of vacuolar degeneration, mitochondrion swell, and apoptosis in renal proximal tubular endothelial cells of I/R group were markedly increased. In this study, R-568 and NPS-2143 (specific activator and inhibitor of CaSR) were used to investigate the role of CaSR in diabetic RI/RI. The results showed that CaSR and CaM were up-regulated, and calcium level was increased in the renal tissue during diabetic RI/RI. In addition, R-568 could significantly enhance levels of BUN, Scr, MDA, NO, and IL-6, and reduce SOD activity and the levels of GSH and IL-10, which may explain why the addition of R-568 increased the injury associated with renal dysfunction, lipid peroxidation, inflammatory response, nitroso-redox imbalance, and pathomorphological injury. The finding in this study that calcium level in R-568 group was significantly higher than that in DM and I/R groups indicates that R-568 activated CaSR, thus increasing Ca level and aggravating diabetic RI/RI. CaM, a key calcium receptor, is the main signal transduction molecule of the intracellular calcium-signaling pathway and mediates regulation of a series of physiological and biochemical reactions caused by Ca2+. CaM usually regulates cell activities via Ca2+/CaM compounds [48]. Excessively high endocellular calcium level will enhance CaM activity to regulate various metabolic enzymes via activating Ca2+/CaM, such as NOS, causing cell metabolic disorders injuries [49]. In the current study, we found that CaSR agonist could further up-regulate the expression of CaM due to the increased intracellular calcium concentration in diabetic RI/RI, and aggravate the renal tissue damage.

This study has limitations. First, the study period of diabetic RI/RI model was only 3 days; therefore, the long-term effect of CaSR on diabetic renal I/R injury remains uncertain. Second, although plentiful data support that the overexpression of CaSR may regulate the level of calcium, causing inflammatory cascade, reactive oxygen species (ROS), abnormal lipid metabolism, and nitroso-redox imbalance from diabetic I/R renal tissues that may act indirectly in redox signaling to turn on apoptosis, the exact underlying mechanisms is still not completely clear in the present study.

The present study demonstrates that activation of CaSR could directly cause elevated calcium levels during diabetic RI/RI, inducing lipid peroxidation, inflammatory response, nitroso-redox imbalance, and triggering damage. CaSR plays a pivotal role in the diabetic RI/ RI.

The authors report no conflicts of interest.

The authors greatly appreciate the editors and the anonymous peer reviewers for their critical reading and insightful comments, which have improved our manuscript substantially. The current study was supported by grants from the Science and Technology Planning Project of Jiaxing (2017AY33056, 2017AY33076), the Science and Technology Planning Project (Laboratory Animal Project) of Zhejiang Province (2015C37130). The sponsors of the study were not involved in study design, data collection, data analysis, data interpretation, or manuscript written.

1.
Suzuki C, Isaka Y, Takabatake Y, Tanaka H, Koike M, Shibata M, Uchiyama Y, Takahara S, Imai E: Participation of autophagy in renal ischemia/reperfusion injury. Biochem Biophys Res Commun 2008; 368: 100-106.
2.
Feng W, Tang R, Ye X, Xue C, Liao Y: Identification of Genes and Pathways Associated with Kidney Ischemia-Reperfusion Injury by Bioinformatics Analyses. Kidney Blood Press Res 2016; 41: 48-54.
3.
Goor Y, Peer G, Iaina A, Blum M, Wollman Y, Chernihovsky T, Silverberg D, Cabili S: Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats. Diabetologia 1996; 39: 1036-1040.
4.
Tong F, Tang X, Luo L, Li X, Xia W, Lu C, Liu D: Sustained delivery of insulin-loaded block copolymers: Potential implications on renal ischemia/reperfusion injury in diabetes mellitus. Biomed Pharmacother 2017; 91: 534-545.
5.
Fadillioglu E, Kurcer Z, Parlakpinar H, Iraz M, Gursul C: Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch Pharm Res 2008; 31: 705-712.
6.
Zhu YB, Zhang YP, Zhang J, Zhang YB: Evaluation of Vitamin C Supplementation on Kidney Function and Vascular Reactivity Following Renal Ischemic Injury in Mice. Kidney Blood Press Res 2016; 41: 460-470.
7.
Kwiatkowska E, Domanski L, Bober J, Safranow K, Romanowski M, Pawlik A, Kwiatkowski S, Ciechanowski K: Urinary Metalloproteinases-9 and -2 and Their Inhibitors TIMP-1 and TIMP-2 are Markers of Early and Long-Term Graft Function After Renal Transplantation. Kidney Blood Press Res 2016; 41: 288-297.
8.
Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC: Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int 1997; 52: 985-991.
9.
Shen X, Hu B, Xu G, Chen F, Ma R, Zhang N, Liu J, Ma X, Zhu J, Wu Y, Shen R: Activation of Nrf2/HO-1 Pathway by Glycogen Synthase Kinase-3beta Inhibition Attenuates Renal Ischemia/Reperfusion Injury in Diabetic Rats. Kidney Blood Press Res 2017; 42: 369-378.
10.
Li X, Hu X, Wang J, Xu W, Yi C, Ma R, Jiang H: Short-Term Hesperidin Pretreatment Attenuates Rat Myocardial Ischemia/Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein Expression via the PI3K/Akt Pathway. Cell Physiol Biochem 2016; 39: 1850-1862.
11.
Li X, Xie Z, Lin M, Huang R, Liang Z, Huang W, Jiang W: Renalase protects the cardiomyocytes of Sprague-Dawley rats against ischemia and reperfusion injury by reducing myocardial cell necrosis and apoptosis. Kidney Blood Press Res 2015; 40: 215-222.
12.
Bai S, Mao M, Tian L, Yu Y, Zeng J, Ouyang K, Yu L, Li L, Wang D, Deng X, Wei C, Luo Y: Calcium sensing receptor mediated the excessive generation of beta-amyloid peptide induced by hypoxia in vivo and in vitro. Biochem Biophys Res Commun 2015; 459: 568-573.
13.
Zhang X, Zhang T, Wu J, Yu X, Zheng D, Yang F, Li T, Wang L, Zhao Y, Dong S, Zhong X, Fu S, Xu CQ, Lu F, Zhang WH: Calcium sensing receptor promotes cardiac fibroblast proliferation and extracellular matrix secretion. Cell Physiol Biochem 2014; 33: 557-568.
14.
Dong S, Li G, Zheng D, Wu J, Sun D, Yang F, Yu X, Li T, Sun A, Liu J, Zhong X, Xu C, Lu F, Zhang W: A novel role for the calcium sensing receptor in rat diabetic encephalopathy. Cell Physiol Biochem 2015; 35: 38-50.
15.
Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner DL, Chae JJ: The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 2012; 492: 123-127.
16.
Weekers L, de Tullio P, Bovy C, Poma L, Maree R, Bonvoisin C, Defraigne JO, Krzesinski JM, Jouret F: Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury. Am J Transl Res 2015; 7: 128-138.
17.
Papadopoulou A, Gole E, Moutafi A, Sfikas C, Oehrl W, Samiotaki M, Papadimitriou A, Papaevagelou V, Nicolaidou P: Calcium sensing receptor in pregnancies complicated by gestational diabetes mellitus. Placenta 2014; 35: 632-638.
18.
Zeleznikova V, Vedralova M, Kotrbova-Kozak A, Zoubkova H, Cerna M, Rychlik I: The intron 4 polymorphism in the calcium-sensing receptor gene in diabetes mellitus and its chronic complications, diabetic nephropathy and non-diabetic renal disease. Kidney Blood Press Res 2014; 39: 399-407.
19.
Malecki R, Fiodorenko-Dumas Z, Jakobsche-Policht U, Malodobra M, Adamiec R: Altered monocyte calcium-sensing receptor expression in patients with type 2 diabetes mellitus and atherosclerosis. J Physiol Pharmacol 2013; 64: 521-527.
20.
Wang R, Xu C, Zhao W, Zhang J, Cao K, Yang B, Wu L: Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem 2003; 270: 2680-2688.
21.
Zhong X, Wang Y, Wu J, Sun A, Yang F, Zheng D, Li T, Dong S, Zhao Y, Yang G, Xu C, Sun D, Lu F, Zhang W: Calcium sensing receptor regulating smooth muscle cells proliferation through initiating cystathionine-gamma-lyase/hydrogen sulfide pathway in diabetic rat. Cell Physiol Biochem 2015; 35: 1582-1598.
22.
Piper HM, Meuter K, Schafer C: Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 2003; 75:S644-648.
23.
Zhang WH, Fu SB, Lu FH, Wu B, Gong DM, Pan ZW, Lv YJ, Zhao YJ, Li QF, Wang R, Yang BF, Xu CQ: Involvement of calcium-sensing receptor in ischemia/reperfusion-induced apoptosis in rat cardiomyocytes. Biochem Biophys Res Commun 2006; 347: 872-881.
24.
Lu FH, Tian Z, Zhang WH, Zhao YJ, Li HL, Ren H, Zheng HS, Liu C, Hu GX, Tian Y, Yang BF, Wang R, Xu CQ: Calcium-sensing receptors regulate cardiomyocyte Ca2+ signaling via the sarcoplasmic reticulum-mitochondrion interface during hypoxia/reoxygenation. J Biomed Sci 2010; 17: 50.
25.
Lu FH, Fu SB, Leng X, Zhang X, Dong S, Zhao YJ, Ren H, Li H, Zhong X, Xu CQ, Zhang WH: Role of the calcium-sensing receptor in cardiomyocyte apoptosis via the sarcoplasmic reticulum and mitochondrial death pathway in cardiac hypertrophy and heart failure. Cell Physiol Biochem 2013; 31: 728-743.
26.
Sun J, Wei T, Bai S, Zhao H, Liu X, Yu J, Li L, Song G, Luan H, Xu C: Calcium-sensing receptor-mediated mitogen-activated protein kinase pathway improves the status of transplanted mouse embryonic stem cells in rats with acute myocardial infarction. Mol Cell Biochem 2017; 431: 151-160.
27.
Hu B, Xu G, Zheng Y, Tong F, Qian P, Pan X, Zhou X, Shen R: Chelerythrine Attenuates Renal Ischemia/ Reperfusion-induced Myocardial Injury by Activating CSE/H2S via PKC/NF-kappaB Pathway in Diabetic Rats. Kidney Blood Press Res 2017; 42: 379-388.
28.
Ozbilgin S, Ozkardesler S, Akan M, Boztas N, Ozbilgin M, Ergur BU, Derici S, Guneli ME, Meseri R: Renal Ischemia/Reperfusion Injury in Diabetic Rats: The Role of Local Ischemic Preconditioning. Biomed Res Int 2016; 2016: 8580475.
29.
Akan M, Ozbilgin S, Boztas N, Celik A, Ozkardesler S, Ergur BU, Guneli E, Sisman AR, Akokay P, Meseri R: Effect of magnesium sulfate on renal ischemia-reperfusion injury in streptozotocin-induced diabetic rats. Eur Rev Med Pharmacol Sci 2016; 20: 1642-1655.
30.
Hu B, Wu Y, Liu J, Shen X, Tong F, Xu G, Shen R: GSK-3beta Inhibitor Induces Expression of Nrf2/TrxR2 Signaling Pathway to Protect against Renal Ischemia/Reperfusion Injury in Diabetic Rats. Kidney Blood Press Res 2016; 41: 937-946.
31.
Xu G, Hu B, Chen G, Yu X, Luo J, Lv J, Gu J: Analysis of Blood Trace Elements and Biochemical Indexes Levels in Severe Craniocerebral Trauma Adults with Glasgow Coma Scale and Injury Severity Score. Biol Trace Elem Res 2015; 164: 192-197.
32.
Xu G, Su R, Li B, Lv J, Sun W, Hu B, Li X, Gu J, Yu X: Trace Element Concentrations in Human Tissues of Death Cases Associated With Secondary Infection and MOF After Severe Trauma. Biol Trace Elem Res. 2015; 168: 335-339.
33.
Hu B, Wu Y, Tong F, Liu J, Shen X, Shen R, Xu G: Apocynin Alleviates Renal Ischemia/Reperfusion Injury Through Regulating the Level of Zinc and Metallothionen. Biol Trace Elem Res 2017; 178: 71-78.
34.
Lu Y, Chen W, Lin C, Wang J, Zhu M, Chen J, Miao C: The protective effects of propofol against CoCl2-induced HT22 cell hypoxia injury via PP2A/CAMKIIalpha/nNOS pathway. BMC Anesthesiol 2017; 17: 32.
35.
Hahn NE, Meischl C, Wijnker PJ, Musters RJ, Fornerod M, Janssen HW, Paulus WJ, van Rossum AC, Niessen HW, Krijnen PA: NOX2, p22phox and p47phox are targeted to the nuclear pore complex in ischemic cardiomyocytes colocalizing with local reactive oxygen species. Cell Physiol Biochem 2011; 27: 471-478.
36.
Xia GY, Sun DJ, Ma JH, Liu Y, Zhao F, Owusu Donkor P, Ding LQ, Chen LX, Qiu F: (+)/(-)-Phaeocaulin A-D, four pairs of new enantiomeric germacrane-type sesquiterpenes from Curcuma phaeocaulis as natural nitric oxide inhibitors. Sci Rep 2017; 7: 43576.
37.
Mathioudakis NN, Giles M, Yeh HC, Haywood C, Jr., Greer RC, Golden SH: Racial differences in acute kidney injury of hospitalized adults with diabetes. J Diabetes Complications 2016; 30: 1129-1136.
38.
Schewel D, Zavareh M, Schewel J, Thielsen T, Schmidt T, Schafer U, Kuck KH, Frerker C: Impact of interaction of diabetes mellitus and impaired renal function on prognosis and the incidence of acute kidney injury in patients undergoing transcatheter aortic valve replacement (TAVR). Int J Cardiol 2017; 232: 147-154.
39.
Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knutson KL, Kane GC, Terzic A, Griffin MD, Nath KA: Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 2007; 72: 1073-1080.
40.
Brooks C, Wei Q, Cho SG, Dong Z: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009; 119: 1275-1285.
41.
Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009; 20: 1744-1753.
42.
Qiang M, Xu Y, Lu Y, He Y, Han C, Liu Y, He R: Autofluorescence of MDA-modified proteins as an in vitro and in vivo probe in oxidative stress analysis. Protein Cell 2014; 5: 484-487.
43.
Youssef MI, Mahmoud AA, Abdelghany RH: A new combination of sitagliptin and furosemide protects against remote myocardial injury induced by renal ischemia/reperfusion in rats. Biochem Pharmacol 2015; 96: 20-29.
44.
Xu G, Gu H, Hu B, Tong F, Liu D, Yu X, Zheng Y, Gu J: PEG-b-(PELG-g-PLL) nanoparticles as TNF-alpha nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications. Int J Nanomedicine 2017; 12: 2243-2254.
45.
Xu S, Chen YH, Tan ZX, Xie DD, Zhang C, Xia MZ, Wang H, Zhao H, Xu DX, Yu DX: Vitamin D3 pretreatment alleviates renal oxidative stress in lipopolysaccharide-induced acute kidney injury. J Steroid Biochem Mol Biol 2015; 152: 133-141.
46.
Yu H, Zhang H, Zhao W, Guo L, Li X, Li Y, Zhang X, Sun Y: Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K/Akt Pathway In vivo and In vitro. Cell Physiol Biochem 2016; 39: 123-136.
47.
Chen F, Wu JL, Fu GS, Mou Y, Hu SJ: Chronic treatment with qiliqiangxin ameliorates aortic endothelial cell dysfunction in diabetic rats. J Cardiovasc Pharmacol Ther 2015; 20: 230-240.
48.
Liu W, Zhang X, Zhao M, Zhang X, Chi J, Liu Y, Lin F, Fu Y, Ma D, Yin X: Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome. Cell Physiol Biochem 2015; 35: 2483-2500.
49.
Huang Y, Zhou Y, Wong HC, Castiblanco A, Chen Y, Brown EM, Yang JJ: Calmodulin regulates Ca2+-sensing receptor-mediated Ca2+ signaling and its cell surface expression. J Biol Chem 2010; 285: 35919-35931.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.